Establishment of age-specific reference levels and achievable doses for children and adults undergoing nuclear medicine exams
Creators
- 1. Department of Medical Physics, PINUM Cancer Hospital, 2019 Faisalabad (Pakistan)
- 2. Molecular Modeling and Simulation Laboratory, Department of Physics, Government College University Faisalabad -GCUF-, Allama Iqbal Road, 38040 Faisalabad (Pakistan)
Description
Reference levels (RLs) and achievable doses (ADs) have been investigated for routine nuclear medicine and molecular imaging procedures across various hospitals. The RLs and ADs were then set at 75. and 50. percentile of the data collected respectively. The minimum and maximum administered activities (in MBq) were asked for 99mTc-DTPA, 99mTc-DMSA, 99mTc-HIDA, 99mTc-MDP, 99mTc-Pertechnetate (for thyroid imaging) and 18F-FDG (whole body imaging), 99mTc-Sestamibi cardiac scan (rest and stress) 2-day protocols, 99mTc-parathyroid and 99mTc-labeled GI bleeding. The pediatrics were divided into three age groups of (> 1-5), (> 5-10) and (> 10-15) years. The observations show that, in most of cases, children are administered higher quantities of radiopharmaceuticals than recommended by guidelines. However, the adults are given right amount of does in most of the imaging procedures. It is shown that findings of the study can enable facilities to compare their radiation doses to the international guidelines and adjust them according to patient body size and weight to get image quality corresponding to right radiation dose. (authors)
Availability note (English)
Available from doi: http://dx.doi.org/10.1051/radiopro/2019019Additional details
Identifiers
Publishing Information
- Journal Title
- Radioprotection
- Journal Volume
- 54
- Journal Issue
- no.3
- Journal Page Range
- p. 187-194
- ISSN
- 0033-8451
INIS
- Country of Publication
- France
- Country of Input or Organization
- France
- INIS RN
- 52098739
- Subject category
- S61: RADIATION PROTECTION AND DOSIMETRY; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CHILDREN; DTPA; FLUORINE 18; NUCLEAR MEDICINE; OPTIMIZATION; PATIENTS; PEDIATRICS; PERTECHNETATES; RADIATION DOSES; RADIATION HAZARDS; RADIATION PROTECTION; RADIOACTIVITY; RADIOPHARMACEUTICALS; RECOMMENDATIONS; TECHNETIUM 99; THYROID
- Descriptors DEC
- AGE GROUPS; AMINO ACIDS; ANIMALS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; CARBOXYLIC ACIDS; CHELATING AGENTS; DOSES; DRUGS; ENDOCRINE GLANDS; FLUORINE ISOTOPES; GLANDS; HAZARDS; HEALTH HAZARDS; HOURS LIVING RADIOISOTOPES; HUMANS; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MAMMALS; MATERIALS; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NUCLEI; ODD-EVEN NUCLEI; ODD-ODD NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANS; OXYGEN COMPOUNDS; PRIMATES; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOPROTECTIVE SUBSTANCES; REFRACTORY METAL COMPOUNDS; RESPONSE MODIFYING FACTORS; TECHNETIUM COMPOUNDS; TECHNETIUM ISOTOPES; TRANSITION ELEMENT COMPOUNDS; VERTEBRATES; YEARS LIVING RADIOISOTOPES
Optional Information
- Notes
- 15 refs.